Functionalizing Cell-Based Therapy for Age-related Macular Degeneration

Marco A. Zarbin

doi:10.1016/j.ajo.2007.01.024

Functionalizing Cell-Based Therapy for Age-related Macular Degeneration

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	681-682
Number of pages	2
Journal	American journal of ophthalmology
Volume	143
Issue number	4
DOIs	https://doi.org/10.1016/j.ajo.2007.01.024
State	Published - Apr 2007

All Science Journal Classification (ASJC) codes

Ophthalmology

Access to Document

10.1016/j.ajo.2007.01.024

Cite this

@article{32a69ab8cf014ad88d34d09a0128af15,

title = "Functionalizing Cell-Based Therapy for Age-related Macular Degeneration",

author = "Zarbin, {Marco A.}",

note = "Funding Information: This study was supported in part by the Foundation Fighting Blindness, Inc, Owings Mills, Maryland, Research to Prevent Blindness, Inc, New York, New York, the New Jersey Lions Eye Research Foundation, Newark, New Jersey, the Eye Institute of New Jersey, Newark, New Jersey, and the Janice Mitchell Vassar and Ashby John Mitchell Fellowship. Dr Zarbin has received grant support from Centocor, Inc, Horsham, Pennsylvania, Theragenics, Inc, Buford, Georgia, and Genentech, South San Francisco, California, and has served as a paid consultant for Novartis, Genentech, Wyeth, Advanced Cell Technology, Inc, and Celgene.",

year = "2007",

month = apr,

doi = "10.1016/j.ajo.2007.01.024",

language = "English (US)",

volume = "143",

pages = "681--682",

journal = "American journal of ophthalmology",

issn = "0002-9394",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Functionalizing Cell-Based Therapy for Age-related Macular Degeneration

AU - Zarbin, Marco A.

N1 - Funding Information: This study was supported in part by the Foundation Fighting Blindness, Inc, Owings Mills, Maryland, Research to Prevent Blindness, Inc, New York, New York, the New Jersey Lions Eye Research Foundation, Newark, New Jersey, the Eye Institute of New Jersey, Newark, New Jersey, and the Janice Mitchell Vassar and Ashby John Mitchell Fellowship. Dr Zarbin has received grant support from Centocor, Inc, Horsham, Pennsylvania, Theragenics, Inc, Buford, Georgia, and Genentech, South San Francisco, California, and has served as a paid consultant for Novartis, Genentech, Wyeth, Advanced Cell Technology, Inc, and Celgene.

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=33947429731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947429731&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2007.01.024

DO - 10.1016/j.ajo.2007.01.024

M3 - Editorial

C2 - 17386276

AN - SCOPUS:33947429731

SN - 0002-9394

VL - 143

SP - 681

EP - 682

JO - American journal of ophthalmology

JF - American journal of ophthalmology

IS - 4

ER -

Functionalizing Cell-Based Therapy for Age-related Macular Degeneration

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this